PLATT DAVID 4/A
4/A · BIOXYTRAN, INC · Filed Nov 18, 2025
Insider Transaction Report
Form 4/AAmended
BIOXYTRAN, INCBIXT
PLATT DAVID
DirectorCEO10% Owner
Transactions
- Other
preferred
2024-10-24$0.55/sh+11,433,448$6,231,229→ 20,038,903 total - Other
preferred
2024-10-24$0.28/sh−14,085,410$4,014,342→ 0 total(indirect: through NDPD Pharma)
Footnotes (3)
- [F1]The shares were returned to treasury and cancelled
- [F2]The total holdings of BIXT by NDPA Pharma, an affiliate whose beneficial ownership includes David Platt, Ola Soderquist and Mike Sheikh were consolidated under indirect ownership in David Platt's filing
- [F3]The shares were issued as payment for the sale of NDPD to Bioxytran